Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Thyroid : Official Journal of the American Thyroid Association|October 27, 2020
Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in <i>BRAF</i> Papillary Thyroid CarcinomaVeronica Valvo, Asumi Iesato, Taylor R Kavanagh, et al.
The European Respiratory Journal|September 25, 2021
Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosisJesse D Kirkpatrick, Ava P Soleimany, Jaideep S Dudani, et al.
Molecular Cancer Research : MCR|September 5, 2014
High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null settingDoug Medvetz, Yang Sun, Chenggang Li, et al.
Cancer Research|September 5, 2006
The isopeptidase USP2a protects human prostate cancer from apoptosisCarmen Priolo, Dan Tang, Mohan Brahamandan, et al.
The Journal of Biological Chemistry|October 11, 2022
Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell deathShikshya Shrestha, Elio Adib, Jewel Imani, et al.
Cancer Research|October 18, 2014
AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancerCarmen Priolo, Saumyadipta Pyne, Joshua Rose, et al.
Clinical Genitourinary Cancer|May 23, 2025
Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell CarcinomaMichel Alchoueiry, Hadi Mansour, Damir Khabibullin, et al.
Oncogene|September 6, 2025
Targeting FSP1 to induce ferroptosis in chromophobe renal cell carcinomaSamer Salem, Tiegang Han, Michel Alchoueiry, et al.
Pageof 5